Initiatives that further the goal of HIV vaccine discovery are highlighted below.
Programs with award dates being made in FY13
Non-human Primate (NHP) Core Functional Genomics, a contract mechanism to ensure standardization and comparability of functional genomics services and assays conducted for these SVEU and DAIDS-supported preclinical NHP studies.
Functional Glycomics in HIV Vaccine Design to stimulate and foster multi-disciplinary investigator- initiated collaborative research that 1) investigates structural and conformational features of glycosylation that may lead to novel HIV vaccine design approaches and 2) elucidates the impact of differential glycosylation on the quality of the immune response to HIV.
HIV Vaccine Research and Design (HIVRAD) program advances concepts further towards the development of a preventive AIDS vaccine.
Programs with award dates in FY2012
Innovation for HIV Vaccine Discovery to support projects that design and develop effective immunogens that may provide long-term protection from acquisition of HIV
Integrated Pre-Clinical AIDS Vaccine Development Program to support preclinical discovery and development leading up to exploratory Phase I clinical trials aimed at advancing a candidate microbicide or strategy to more advanced clinical trials.
Centers for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) focused on multi-pronged approaches to accelerate HIV vaccine development by addressing key immunological roadblocks to the discovery and development of a safe and effective HIV vaccine.
Last Updated August 25, 2010